These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3530116)
21. Whither carboplatin? A replacement for or an alternative to cisplatin? Gil A J Clin Oncol; 1987 Dec; 5(12):2041-2. PubMed ID: 3316520 [No Abstract] [Full Text] [Related]
22. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system. Rice JR; Gerberich JL; Nowotnik DP; Howell SB Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041 [TBL] [Abstract][Full Text] [Related]
23. A comparison of the platinum analogues in bladder cancer cell lines. Powles T; Perry J; Shamash J; Liu W; Oliver T; Joel S Urol Int; 2007; 79(1):67-72. PubMed ID: 17627172 [TBL] [Abstract][Full Text] [Related]
24. [Biological parameters of a standardized tumor model for chemotherapeutical and toxicological testing (author's transl)]. Fichtner I; Arnold W; Pehl E Arch Geschwulstforsch; 1979; 49(5):391-407. PubMed ID: 518249 [TBL] [Abstract][Full Text] [Related]
25. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes. Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335 [TBL] [Abstract][Full Text] [Related]
26. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A. Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316 [TBL] [Abstract][Full Text] [Related]
27. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334 [TBL] [Abstract][Full Text] [Related]
28. Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma. Sugiyama T; Sadzuka Y Clin Cancer Res; 1999 Feb; 5(2):413-6. PubMed ID: 10037191 [TBL] [Abstract][Full Text] [Related]
29. Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay. Schroyens WA; Meeker JB; Dodion P; Stryckmans PA; Rozencweig M Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1309-12. PubMed ID: 3053206 [TBL] [Abstract][Full Text] [Related]
30. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride. Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128 [TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model. Garnuszek P; Karczmarczyk U; Maurin M Nucl Med Biol; 2008 Jul; 35(5):605-13. PubMed ID: 18589305 [TBL] [Abstract][Full Text] [Related]
32. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631 [TBL] [Abstract][Full Text] [Related]
33. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826 [TBL] [Abstract][Full Text] [Related]
34. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318 [TBL] [Abstract][Full Text] [Related]
35. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. Elliott WL; Roberts BJ; Howard CT; Leopold WR Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790 [TBL] [Abstract][Full Text] [Related]
36. Carboplatin, an active drug in advanced head and neck cancer. de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443 [TBL] [Abstract][Full Text] [Related]
37. Flat revertant inducers, styryl diphenylamine derivatives, inhibit growth and metastasis of murine tumor cells in vivo. Ohizumi I; Tanemura M; Tsunenari T; Sato K; Kozono T; Kaiho S Anticancer Res; 1997; 17(1A):393-400. PubMed ID: 9066683 [TBL] [Abstract][Full Text] [Related]
38. New anticancer drugs under clinical trials in Japan. Ogawa M; Ariyoshi Y Hematol Oncol Clin North Am; 1994 Apr; 8(2):277-87. PubMed ID: 8040141 [TBL] [Abstract][Full Text] [Related]
39. [Estrogenic and antineoplastic activity of a series of transformed analogs of estrone and estradiol]. Sorokina IB; Barkova TI; Zakharychev AA; Chigir' RN; Ananchenko SN Izv Akad Nauk SSSR Biol; 1973; 5():664-70. PubMed ID: 4761310 [No Abstract] [Full Text] [Related]
40. Evaluation of antitumor and antimetastatic activity of pepstatin A in some experimental tumor models. Tumminello FM; Leto G; Gebbia N; Rausa L; Bernacki RJ J Chemother; 1989 Jul; 1(4 Suppl):1135-8. PubMed ID: 16315374 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]